Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ONXX -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (667)	9/24/2000 11:47:37 PM
From: Larry Liebman	Read Replies (1) \| Respond to of 810

It's interesting to see the banter over ONXX. I've held a speculative stake for 2 years based on information like: "Warner-Lambert will make an upfront payment in ONXX over two years totalling $15 million and will provide $40 million in funding for Phase 111 trials and other ongoing clinical developmental studies for ONYX-015. In addition, Warner-Lambert will provide support and development of two new products.In addition to the committed funding, over $100 million could be payable in the achievement of milestones for the products".- 10/18/99 ONXX and Bayer enter Phase 1 trials with a Ras pathway inhibitor sharing costs and profits- 7/18/00 ONXX extends its Armed Therapeutic Virus (ATV) platform. ONXX adds to Board of Directors with CEO of EXEL, and President of Pharmcia Diagnostics. I won't comment on the Phase 11 results, other than I assume Warner was pleased with the data. I guess I'm fascinated with the debate over a $300 million cap cancer company. ONXX could be CLPA...or it could be IMCL. My question to the discussants: How do you make an informed decision about what you purchase? What is material to making a decision to hold any biotech stock? What stocks have you failed with? What other biotechs are you invested in?

To: scaram(o)uche who wrote (667)	9/24/2000 11:49:07 PM
From: Larry Liebman	Respond to of 810

It's interesting to see the banter over ONXX. I've held a speculative stake for 2 years based on information like: "Warner-Lambert will make an upfront payment in ONXX over two years totalling $15 million and will provide $40 million in funding for Phase 111 trials and other ongoing clinical developmental studies for ONYX-015. In addition, Warner-Lambert will provide support and development of two new products.In addition to the committed funding, over $100 million could be payable in the achievement of milestones for the products".- 10/18/99 ONXX and Bayer enter Phase 1 trials with a Ras pathway inhibitor sharing costs and profits- 7/18/00 ONXX extends its Armed Therapeutic Virus (ATV) platform. ONXX adds to Board of Directors with CEO of EXEL, and President of Pharmcia Diagnostics. I won't comment on the Phase 11 results, other than I assume Warner was pleased with the data. I guess I'm fascinated with the debate over a $300 million cap cancer company. ONXX could be CLPA...or it could be IMCL. My question to the discussants: How do you make an informed decision about what you purchase? What is material to making a decision to hold any biotech stock? What stocks have you failed with? What other biotechs are you invested in?